rBS/WC霍乱疫苗对细菌性感染性腹泻的效果:中国广州2-6岁儿童的检测阴性研究
在广州2-6岁感染性腹泻儿童中开展检测阴性设计研究,经1:4倾向评分匹配后纳入316对共1306人。结果显示,≥1剂rBS/WC疫苗对细菌性感染性腹泻的总保护效果为57.7%(95%CI:30.3-74.3),接种后6个月内保护效果最佳,为74.8%(95%CI:16.8-95.6),随后呈下降趋势。
要点
- ≥1剂rBS/WC疫苗对2-6岁儿童细菌性感染性腹泻总保护效果为57.7%(95%CI:30.3-74.3)。
- 接种后6个月内保护效果最佳,为74.8%(95%CI:16.8-95.6),之后呈下降趋势。
- 对沙门菌保护效果为54.6%(95%CI:22.1-73.5),对大肠埃希菌为69.2%(95%CI:-133.7-95.9)。
核心结论
- 研究结果支持rBS/WC疫苗接种项目在真实世界中可有效预防儿童细菌性腹泻。
- 作者认为,对细菌性腹泻易感人群,霍乱疫苗是一个良好的预防选择。
研究设计与样本
- 采用检测阴性病例对照设计,研究对象为广州市2-6岁感染性腹泻儿童。
- 基于研究对象基本特征进行1:4倾向评分匹配,校正混杂因素后计算疫苗效果。
- 共纳入2796例实验室确诊感染性腹泻儿童,倾向评分匹配后成功匹配316对,合计1306人。
主要发现
- 条件logistic回归分析显示,≥1剂rBS/WC疫苗对2-6岁儿童细菌性感染性腹泻的总保护效果为57.7%(95%CI:30.3-74.3)。
- 接种后6个月内保护效果最佳,为74.8%(95%CI:16.8-95.6),之后呈下降趋势。
- 疫苗对沙门菌的保护效果为54.6%(95%CI:22.1-73.5),对大肠埃希菌的保护效果为69.2%(95%CI:-133.7-95.9)。
- 分层分析显示,卫生习惯良好的健康儿童接种疫苗后保护效果的点估计值更高。
临床怎么用
- 作者认为,对细菌性腹泻易感人群,霍乱疫苗是一个良好的预防选择。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Recombinant B-subunit/Whole Cell Cholera Vaccine (rBS/WC) represents a new and effective way to protect against and control diarrhea. A test-negative case-control study was conducted to investigate the cross-protective effect of cholera vaccine immunization against bacterial infectious diarrhea in a real-world setting. METHODS: Using a test-negative design, children aged 2-6 years with infectious diarrhea in Guangzhou City were selected as study subjects. A 1:4 propensity score matching based on the basic characteristics of the included study subjects, and vaccine effects were calculated after correcting for confounders. RESULTS: A total of 2796 children with laboratory-confirmed infectious diarrhea were enrolled in the study, and 316 pairs were successfully enrolled in the matching after Propensity Score Matching(PSM), totaling 1306. By conditional logistic regression analysis, The results showed that the total protective effect of ≥1 dose of rBS/WC vaccine against bacterial infectious diarrhea in children aged 2-6 years was 57.7 % (95 % CI: 30.3-74.3); the rBS/WC vaccine had the best protective effect of 74.8 % (95 % CI: 16.8-95.6) within 6 months of vaccination and then showed a decreasing trend. The vaccine's protective effect was 54.6 % (95 % CI: 22.1-73.5) against Salmonella and 69.2 % (95 % CI: -133.7-95.9) against Escherichia coli. Stratified analyses revealed higher point estimates of the protective effect obtained by vaccination among healthy children with good hygiene. CONCLUSIONS: These findings support the idea that the rBS/WC vaccination program is effective in the real world in preventing bacterial diarrhea in children. For people who are susceptible to bacterial diarrhea, the cholera vaccine is a good preventive option.
引用
- Long Q, Wang H, He Q, et al. Effectiveness of rBS/WC cholera vaccine against bacterial infectious diarrhea: A test-negative study on children aged 2-6 years in Guangzhou China. Vaccine. 2025. PMID: 40294478. doi:10.1016/j.vaccine.2025.127139
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。